Zosano Pharma Corp.
(NASDAQ : ZSAN)

( )
ZSAN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -2.99%576.911.0%$828.43m
DHRDanaher Corp. -3.85%303.830.7%$644.33m
ABTAbbott Laboratories -1.47%118.810.8%$541.71m
ISRGIntuitive Surgical, Inc. -2.10%992.492.3%$519.72m
MDTMedtronic Plc -2.21%125.900.6%$451.27m
BDXBecton, Dickinson & Co. -0.62%249.881.0%$351.66m
ALGNAlign Technology, Inc. -3.38%677.326.3%$324.46m
BAXBaxter International, Inc. 0.22%80.751.8%$315.74m
HRCHill-Rom Holdings, Inc. 0.19%149.572.2%$312.56m
IDXXIDEXX Laboratories, Inc. -3.57%626.853.8%$298.98m
DXCMDexCom, Inc. -2.21%536.947.8%$289.83m
SYKStryker Corp. -2.12%267.691.3%$269.52m
BSXBoston Scientific Corp. -1.69%43.711.0%$256.32m
ZBHZimmer Biomet Holdings, Inc. -0.47%150.831.7%$244.56m
AAgilent Technologies, Inc. -3.86%159.961.6%$224.76m

Company Profile

Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. The firm focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. It offers Qtrypta, a formulation of zolmitriptan delivered utilizing the intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA.